Nation
World
Politics
Sports
Business
Entertainment
Life
Tech
Science
Opinion
Crime
Health
Oddities

Specific Lots Of Detect Covid-19 Test Recalled

Por: RTTNews Health December 14, 2022

thumbnail

Detect, Inc. has recalled specific lots of the Detect Covid-19 Test citing possibility to give false negative results, the U.S. Food and Drug Administration said. The reliability of positive test results is not affected.The molecular, over-the-counter test is used to identify SARS-CoV-2, the virus that causes Covid-19, in self-collected nasal swabs.The recall affects a total of 11,102 tests shipped to customers from July 26, 2022 through August... + full article



Similar News

Specific Lots Of Detect Covid-19 Test Recalled

RTTNews USA Health December 14, 2022

thumbnailDetect, Inc. has recalled specific lots of the Detect Covid-19 Test citing possibility to give false negative results, the U.S. Food and Drug Administration said. The reliability of positive test results is not affected.The molecular, over-the-counter test is used to identify... + más

Detect issues COVID-19 test recall over false negatives | 10 WBNS

Specific Lots Of Detect Covid-19 Test Recalled | RTTNews


Detect issues COVID-19 test recall over false negatives

10 WBNS USA Nation December 14, 2022

thumbnailWASHINGTON — Around 11,000 at-home tests are being recalled because of the possibility of false negative results. three specific lots of its over-the-counter nasal swab test.  In total, the recall affects 11,102 tests to customers from July 26, 2022 through Aug. 26, 2022. All... + más

Tesla Recall: What Happened And What Will It Cost TSLA Stockholders? | Forbes

Specific Lots Of Detect Covid-19 Test Recalled | RTTNews


FDA announces COVID-19 test recall, tests prone to false positives

WPTV USA Business December 13, 2022

thumbnailThe Food and Drug Administration said on Tuesday that some COVID-19 tests are being recalled as they are prone to false positive results.The tests were made by Detect Inc. and shipped to customers from July 26-Aug. 26. The FDA said the reliability of positive results is not... + más

FDA Updates COVID-19 Test Policy; Asks Developers To Seek Premarket Review Pathways | RTTNews

FDA Updates COVID-19 Test Policy; Asks Developers To Seek Premarket Review Pathways | RTTNews


The Overlooked Solar Power Potential of U.S. Parking Lots

Time USA Nation December 09, 2022

thumbnailFor climate campaigners, French parking lots are now very exciting places. In November, France’s senate approvedwhich would require the owners of almost all large parking lots to install They would have to cover 50% of the lots’ surface area by 2028—or face a heavy monthly... + más

A ‘Secret’ Spectacular Solar Eclipse Is Coming Soon And You Need To Make Plans Now | Forbes

3 compelling reasons to go solar right now | CBS News


Parents beware: Dangerous, recalled toys are still on sale

CNN USA Business November 18, 2022

thumbnailNew York CNNBusiness  —  Parents shopping for their kids this holiday season need to be alert and carefully examine toys before they buy them because recalled and counterfeit toys are being sold online, a consumer report said Thursday. The 37th annual “” toy safety... + más

Macy’s Partnership Signals A Brand New Future For Toys R Us | Forbes

Parents agree play is a form of self-care for kids: poll | New York Post


New test can detect plaques early in the disease: Alzheimer's Q&A

The Advocate USA Health November 16, 2022

thumbnailWhat is the Lumipulse test for Alzheimer’s disease?In May, the U.S. Food and Drug Administration permitted marketing of the Lumipulse (G B-Amyloid Ratio [1-42/1-40]) test to Fujirebio Diagnostics, Inc. of Malvern, Pennsylvania. The test, which was granted Breakthrough Device... + más

Reimagining Alzheimer’s (Part 4): Cautious Optimism For A New Alzheimer’s Disease Treatment | Forbes

Why Isn’t There an Effective Alzheimer’s Treatment Yet? | Slate


New test can detect plaques early in the disease: Alzheimer's Q&A

The Advocate USA Health September 17, 2022

thumbnailWhat is the Lumipulse test for Alzheimer’s disease?In May, the U.S. Food and Drug Administration permitted marketing of the Lumipulse (G B-Amyloid Ratio [1-42/1-40]) test to Fujirebio Diagnostics, Inc. of Malvern, Pennsylvania. The test, which was granted Breakthrough Device... + más

Variety of factors play a role in the development of Alzheimer's | The Advocate

Alzheimer's Q&A: Sildenafil has potential as Alzheimer's drug | The Advocate



About iurex | Privacy Policy | Disclaimer |